Showing 61 - 80 of 675 results
ANSTO’s National Deuteration Facility has provided deuterated cholesterol for international research to gain a better understanding of how the Spike protein of the COVID virus, SARS-Co-V-2, infects human cells through a membrane fusion mechanism.
Australia’s new state-of-the-art nuclear medicine facility gets green light.
In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.
Proposals at the Australian Centre for Neutron Scattering and National Deuteration Facility.
ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.
ANSTO provides access to specialised facilities and capabilities by application. Please ensure that you contact the relevant ANSTO scientist for advice before submitting a proposal.
See details of previously published customer updates from our Health products team.
Experts at ANSTO’s Australian Synchrotron are prioritising work that could hold the key to fast-tracking the development of a vaccine for COVID-19.
Voucher scheme accelerating medical research
ANSTO is one of the world's leading providers of irradiation services for silicon ingots, which are used by the multimillion dollar electronics industry across Europe and Asia. Each year, ANSTO irradiates more than 50 tonnes of silicon.
Routine transport of spent nuclear fuel